Unbiased AI-powered news
1 stories related to this topic, newest first.
The GuardianAdvisers to the Food and Drug Administration will meet on 23-24 July to consider easing restrictions on seven research peptides currently sold in a gray market. The discussion follows a 2023 ban on compounding pharmacies producing the substances due to safety concerns.